drugset / Trial / NCT00228462

Relapse Prevention, RoW: Study to Evaluate Prevention of Relapse in Patients in Stable Chronic Schizophrenia Receiving Either Seroquel or Placebo

NCT00228462

Phase 3 Completed 197 enrolled AstraZeneca
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is being carried out to see if quetiapine (Seroquel) is effective in preventing patients from a schizophrenic relapse when studied for a long time (1 year) and if so, how it compares with non-active treatment.

Timeline

Start
2005-03
Primary completion
Completion
2006-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Quetiapine Small molecule

Indications